FIELD: medicine.
SUBSTANCE: invention relates to composition for pain treatment, as well as for treatment of osteoarthritis in patient with joint pain. Claimed composition includes 0.1-10 wt % of non-steroid anti-inflammatory compound - sodium diclofenac or sodium diclofenac solution, 25-60% wt dimethylsulfoxide, ethanol, propylene glycol, thickening agent, selected from hydroxypropylcellulose and polymers-carbomers and glycerol in case of thickening agent is carbomer, water and has viscosity equal to 500-5000 centipoise. Invention also relates to medication for treatment pain, as well as treatment of osteoarthritis in patient, with joint pain, which contains said composition.
EFFECT: invention ensures excellent means of sodium diclofenac delivery through skin, which demonstrates better duration of drying, greater viscosity, greater pharmacokinetic absorption in vivo and which can be applied for topic pain treatment.
13 cl, 12 dwg, 17 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM FOR DOSED DISTRIBUTION | 2013 |
|
RU2637420C2 |
| PHARMACEUTICAL COMPOSITION FOR TOPIC APPLICATION | 2008 |
|
RU2468794C2 |
| DELIVERY SYSTEMS FOR LOCAL APPLICATION FOR ACTIVE SUBSTANCES | 2018 |
|
RU2777644C2 |
| APPLICATION OF FILM-FORMING POLYMERS FROM GROUP OF POLYURETHANES FOR HAIR CARE AND PHARMACEUTICAL PREPARATIONS, WHICH CONTAIN THESE POLYMERS | 2006 |
|
RU2437680C2 |
| CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
| DICLOFENAC SODIUM COMPOSITION FOR TOPICAL APPLICATION | 2015 |
|
RU2702898C2 |
| COMPOSITIONS OF NAPROXEN FOR TOPICAL USE IN GEL FORM | 2020 |
|
RU2809702C2 |
| PHARMACEUTICAL COMPOSITION FOR HISTONE DEACETYLASE INHIBITORS | 2011 |
|
RU2625758C2 |
| TRANSDERMAL SYSTEM FOR VARENICLINE | 2006 |
|
RU2388461C2 |
| HYDROPHILIC PHARMACEUTICAL COMPOSITION SHOWING ANTI-INFLAMMATORY EFFECT | 1999 |
|
RU2140258C1 |
